First AccelrysWorld Conference Opens In San Diego

Scientific Forum Features Nobel Laureates, Industry Analysts, Leading Research Organizations

Accelrys To Provide Technology For Functional Annotation Of Confirmant’s Protein Atlas Of The Human Genome(Tm)

Accelrys Inc., a wholly owned subsidiary of Pharmacopeia, Inc. (NASDAQ: PCOP), and Confirmant Ltd., a provider of innovative bio-information, today announced a technology software alliance that will result in a novel database consisting of highly annotated proteins which could provide the pharmaceutical industry with crucial data for prioritizing the selection of drug targets and accelerating drug discovery.

IBM, United Devices And Accelrys Aid U.S. Department Of Defense In Search For Smallpox Cure

Smallpox Research Grid Project to link more than two million computers